Sandra Meyer

Publications

• Evolution of Hepatitis C Virus Quasispecies During Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir
  Antimicrobial Agents and Chemotherapy. May, 2015  |   Pubmed ID: 25712364
• Trends in Darunavir Resistance-associated Mutations and Phenotypic Resistance in Commercially Tested United States Clinical Samples Between 2006 and 2012
  AIDS Research and Human Retroviruses. Jun, 2015  |   Pubmed ID: 25684627
• An OPTIMIZE Study Retrospective Analysis for Management of Telaprevir-treated Hepatitis C Virus (HCV)-infected Patients by Use of the Abbott RealTime HCV RNA Assay
  Journal of Clinical Microbiology. Apr, 2015  |   Pubmed ID: 25653396
• DPP4-deficient Congenic Rats Display Blunted Stress, Improved Fear Extinction and Increased Central NPY
  Psychoneuroendocrinology. Mar, 2015  |   Pubmed ID: 25635612
• Prevalence of the Hepatitis C Virus NS3 Polymorphism Q80K in Genotype 1 Patients in the European Region
  Antiviral Research. Apr, 2015  |   Pubmed ID: 25614456
• Effect of Agrobacterium Strain and Plasmid Copy Number on Transformation Frequency, Event Quality and Usable Event Quality in an Elite Maize Cultivar
  Plant Cell Reports. May, 2015  |   Pubmed ID: 25558819
• Virology Analyses of HCV Isolates from Genotype 1-infected Patients Treated with Simeprevir Plus Peginterferon/ribavirin in Phase IIb/III Studies
  Journal of Hepatology. May, 2015  |   Pubmed ID: 25445400
• Low-density Lipoprotein and Other Predictors of Response with Telaprevir-based Therapy in Treatment-experienced HCV Genotype 1 Patients: REALIZE Study
  Liver International : Official Journal of the International Association for the Study of the Liver. Feb, 2015  |   Pubmed ID: 25319731
• Modeling Viral Evolutionary Dynamics After Telaprevir-based Treatment
  PLoS Computational Biology. Aug, 2014  |   Pubmed ID: 25101970
• Deep-sequencing Analysis of the Gene Encoding the Hepatitis C Virus Nonstructural 3-4A Protease Confirms a Low Prevalence of Telaprevir-resistant Variants at Baseline and the End of the REALIZE Study
  The Journal of Infectious Diseases. Dec, 2014  |   Pubmed ID: 24943725
• Virologic Characterization of Genotype 4 Hepatitis C Virus Variants in Patients Treated with Telaprevir
  Virology Journal. 2014  |   Pubmed ID: 24886541
• Synthesis and Pharmacological Evaluation of a New Series of Radiolabeled Ligands for 5-HT7 Receptor PET Neuroimaging
  Nuclear Medicine and Biology. Apr, 2014  |   Pubmed ID: 24607435
• Patterns of Viral Load Decline with Telaprevir-based Therapy in Patients with Genotype 1 Chronic HCV Infection
  Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology. Mar, 2014  |   Pubmed ID: 24462470
• Telaprevir Twice Daily is Noninferior to Telaprevir Every 8 Hours for Patients with Chronic Hepatitis C
  Gastroenterology. Mar, 2014  |   Pubmed ID: 24316262
• Telaprevir Activity in Treatment-naive Patients Infected Hepatitis C Virus Genotype 4: a Randomized Trial
  The Journal of Infectious Diseases. Sep, 2013  |   Pubmed ID: 23801602
• Duplicated STM-like KNOX I Genes Act in Floral Meristem Activity in Eschscholzia Californica (Papaveraceae)
  Development Genes and Evolution. May, 2013  |   Pubmed ID: 23636178
• Evolution of Treatment-emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials
  Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. Jul, 2013  |   Pubmed ID: 23575197
• Virological Analysis of Once-daily and Twice-daily Darunavir/ritonavir in the ODIN Trial of Treatment-experienced Patients
  Antiviral Therapy. 2013  |   Pubmed ID: 23558157
• Limited Impact of IL28B Genotype on Response Rates in Telaprevir-treated Patients with Prior Treatment Failure
  Journal of Hepatology. May, 2013  |   Pubmed ID: 23321318
• Sustained Virologic Response Rates with Telaprevir by Response After 4 Weeks of Lead-in Therapy in Patients with Prior Treatment Failure
  Journal of Hepatology. Mar, 2013  |   Pubmed ID: 23183521
• Hepatitis C Virus Variants with Decreased Sensitivity to Direct-acting Antivirals (DAAs) Were Rarely Observed in DAA-naive Patients Prior to Treatment
  Journal of Virology. Feb, 2013  |   Pubmed ID: 23152524
• Characterization of Telaprevir Treatment Outcomes and Resistance in Patients with Prior Treatment Failure: Results from the REALIZE Trial
  Hepatology (Baltimore, Md.). Dec, 2012  |   Pubmed ID: 22806681
• Hepatitis C Viral Evolution in Genotype 1 Treatment-naïve and Treatment-experienced Patients Receiving Telaprevir-based Therapy in Clinical Trials
  PloS One. 2012  |   Pubmed ID: 22511937
• Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-experienced Patients in TITAN
  Current HIV Research. Mar, 2012  |   Pubmed ID: 22339125
• Telaprevir for Retreatment of HCV Infection
  The New England Journal of Medicine. Jun, 2011  |   Pubmed ID: 21696308
• Multipotent Adult Germline Stem Cells and Embryonic Stem Cells Functional Proteomics Revealed an Important Role of Eukaryotic Initiation Factor 5A (Eif5a) in Stem Cell Differentiation
  Journal of Proteome Research. Apr, 2011  |   Pubmed ID: 21344951
• Virological Characterization of Patients Failing Darunavir/ritonavir or Lopinavir/ritonavir Treatment in the ARTEMIS Study: 96-week Analysis
  Antiviral Therapy. 2011  |   Pubmed ID: 21311113
• In Vitro Susceptibility and Virological Outcome to Darunavir and Lopinavir Are Independent of HIV Type-1 Subtype in Treatment-naive Patients
  Antiviral Therapy. 2010  |   Pubmed ID: 21149923
• Digital Gene Expression Signatures for Maize Development
  Plant Physiology. Nov, 2010  |   Pubmed ID: 20833728
• Short Communication: Activity of Etravirine on Different HIV Type 1 Subtypes: in Vitro Susceptibility in Treatment-naive Patients and Week 48 Pooled DUET Study Data
  AIDS Research and Human Retroviruses. Jun, 2010  |   Pubmed ID: 20507207
• Schistosoma Mansoni Worm Glycolipids Induce an Inflammatory Phenotype in Human Dendritic Cells by Cooperation of TLR4 and DC-SIGN
  Molecular Immunology. Apr, 2010  |   Pubmed ID: 20170964
• Etravirine Limits the Emergence of Darunavir and Other Protease Inhibitor Resistance-associated Mutations in the DUET Trials
  AIDS (London, England). Mar, 2010  |   Pubmed ID: 20160633
• [Drug-induced Delirium]
  Therapeutische Umschau. Revue Thérapeutique. Feb, 2010  |   Pubmed ID: 20131216
• [Diagnosis of Delirium]
  Therapeutische Umschau. Revue Thérapeutique. Feb, 2010  |   Pubmed ID: 20131214
• Glycolytic Metabolism and Tumour Response to Fractionated Irradiation
  Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. Jan, 2010  |   Pubmed ID: 20036432
• Inulin Solid Dispersion Technology to Improve the Absorption of the BCS Class IV Drug TMC240
  European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V. Feb, 2010  |   Pubmed ID: 19861163
• Co-localisation of Hypoxia and Perfusion Markers with Parameters of Glucose Metabolism in Human Squamous Cell Carcinoma (hSCC) Xenografts
  International Journal of Radiation Biology. Nov, 2009  |   Pubmed ID: 19895274
• Efficacy and Safety of Darunavir/ritonavir in Treatment-experienced HIV Type-1 Patients in the POWER 1, 2 and 3 Trials at Week 96
  Antiviral Therapy. 2009  |   Pubmed ID: 19812449
• Multipotent Adult Germline Stem Cells and Embryonic Stem Cells: Comparative Proteomic Approach
  Journal of Proteome Research. Dec, 2009  |   Pubmed ID: 19810753
• Characterization of Virologic Failure Patients on Darunavir/ritonavir in Treatment-experienced Patients
  AIDS (London, England). Sep, 2009  |   Pubmed ID: 19474650
• Transglycosylation-based Fluorescent Labeling of 6-gala Series Glycolipids by Endogalactosylceramidase
  Glycobiology. Jul, 2009  |   Pubmed ID: 19389917
• Influence of Baseline Protease Inhibitor Resistance on the Efficacy of Darunavir/ritonavir or Lopinavir/ritonavir in the TITAN Trial
  Journal of Acquired Immune Deficiency Syndromes (1999). Dec, 2008  |   Pubmed ID: 19202459
• Efficacy of Once-daily Darunavir/ritonavir 800/100 Mg in HIV-infected, Treatment-experienced Patients with No Baseline Resistance-associated Mutations to Darunavir
  Journal of Acquired Immune Deficiency Syndromes (1999). Oct, 2008  |   Pubmed ID: 18769351
• Efficacy and Safety of Once-daily Darunavir/ritonavir Versus Lopinavir/ritonavir in Treatment-naive HIV-1-infected Patients at Week 48
  AIDS (London, England). Jul, 2008  |   Pubmed ID: 18614861
• Resistance Profile of Darunavir: Combined 24-week Results from the POWER Trials
  AIDS Research and Human Retroviruses. Mar, 2008  |   Pubmed ID: 18327986
• Response to "key Amprenavir Resistance Mutations Counteract Dramatic Efficacy of Darunavir in Highly Experienced Patients"
  AIDS (London, England). Jan, 2008  |   Pubmed ID: 18090413
• The C-type Lectin L-SIGN Differentially Recognizes Glycan Antigens on Egg Glycosphingolipids and Soluble Egg Glycoproteins from Schistosoma Mansoni
  Glycobiology. Oct, 2007  |   Pubmed ID: 17621595
• Safety and Efficacy of Darunavir (TMC114) with Low-dose Ritonavir in Treatment-experienced Patients: 24-week Results of POWER 3
  Journal of Acquired Immune Deficiency Syndromes (1999). Sep, 2007  |   Pubmed ID: 17621237
• One-step Biotinylation Procedure for Carbohydrates to Study Carbohydrate-protein Interactions
  Analytical Biochemistry. Jul, 2006  |   Pubmed ID: 16713984
• Discovery of Complex Mixtures of Novel Long-chain Quorum Sensing Signals in Free-living and Host-associated Marine Alphaproteobacteria
  Chembiochem : a European Journal of Chemical Biology. Dec, 2005  |   Pubmed ID: 16283687
• DC-SIGN Mediates Binding of Dendritic Cells to Authentic Pseudo-LewisY Glycolipids of Schistosoma Mansoni Cercariae, the First Parasite-specific Ligand of DC-SIGN
  The Journal of Biological Chemistry. Nov, 2005  |   Pubmed ID: 16155001
• TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active Against Protease Inhibitor-resistant Viruses, Including a Broad Range of Clinical Isolates
  Antimicrobial Agents and Chemotherapy. Jun, 2005  |   Pubmed ID: 15917527
• TMC114/ritonavir Substitution for Protease Inhibitor(s) in a Non-suppressive Antiretroviral Regimen: a 14-day Proof-of-principle Trial
  AIDS (London, England). Jun, 2005  |   Pubmed ID: 15905675
• Design of HIV-1 Protease Inhibitors Active on Multidrug-resistant Virus
  Journal of Medicinal Chemistry. Mar, 2005  |   Pubmed ID: 15771440
• Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor
  Journal of Medicinal Chemistry. Mar, 2005  |   Pubmed ID: 15771427
• Short-time Infusion of Fish Oil-based Lipid Emulsions, Approved for Parenteral Nutrition, Reduces Monocyte Proinflammatory Cytokine Generation and Adhesive Interaction with Endothelium in Humans
  Journal of Immunology (Baltimore, Md. : 1950). Nov, 2003  |   Pubmed ID: 14568963
• The German Network of Excellence for Viral Hepatitis (Hep-Net)
  Hepatology (Baltimore, Md.). Sep, 2003  |   Pubmed ID: 12939578